Suchergebnisse - "Uldrick, Thomas S"

PubPharm (6)

1

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease

enthalten in: The Journal of clinical investigation | 2019

von Fajgenbaum, D. | Langan, R. | Japp, A. | +20

CommentIn: J Clin Invest. 2019 Oct 1;129(10):4086-4088. - PMID 31524635

2

Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease

enthalten in: Hematology/oncology clinics of North America | 2018

von Lurain, K. | Yarchoan, R. | Uldrick, T.

3

Primary effusion lymphoma and concurrent progressive Kaposi sarcoma associated with elevated interleukin-6

enthalten in: Blood | 2016

von Pratt, D. | Uldrick, T.

4

Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation : Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2016

von Polizzotto, M. | Uldrick, T. | Wyvill, K. | +12

ErratumIn: Clin Infect Dis. 2018 Mar 5;66(6):985. - PMID 29370384

5

Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease

enthalten in: Blood | 2014

von Uldrick, T. | Polizzotto, M. | Aleman, K. | +9

6

Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease

enthalten in: Blood | 2013

von Polizzotto, M. | Uldrick, T. | Wang, V. | +10

1
[1]